The Delaware hearings are viewed as the greatest near-term chance that the class actions against ranitidine manufacturers will be revived, and whether GSK may consider additional settlements.

It is also facing a class action suit alleging economic injury ... business - although it says it is not a party to any of the Zantac claims. Meanwhile, Sanofi, Pfizer and Boehringer Ingelheim ...

Rosenberg dismissed every Zantac lawsuit filed in the multidistrict litigation class in December 2022, said Miller & Zois Attorneys at Law. That still left cases in state courts. The Financial ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

due to the size of the class and final amounts still not approved, we do not expect swift settlement payments." To apply for a cash advance lawsuit loan from your anticipated GSK Zantac lawsuit ...

(RTTNews) - GSK plc (GSK, GSK.L) announced that it has reached agreements with 10 plaintiff firms representing approximately 93% (around 80,000) of the Zantac (ranitidine) product liability cases ...

The Zantac dispute stems from 2019 ... legal claims relating to alleged privacy breaches in the Netherlands. The class action claims are currently subject to an appeal. TikTok, owned by Beijing ...

(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement over claims its indigestion drug caused cancers. The British drug giant has agreed to pay up to $2.2bn ...